ScholarIQanswers from OpenAlex

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases

PaperCitations, authors & open-access status

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases have?

ScholarIQcitation count

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases has 104 citations in the OpenAlex counts ScholarIQ stores.

When was Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases published?

ScholarIQyear

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases has 2021 year in the ScholarIQ index.

What is the open-access status of Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases?

ScholarIQoa status

Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases has hybrid oa status in the ScholarIQ index.

What is the DOI of Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases?

ScholarIQdoi

The DOI for Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases is on the source record.

What is the PMID of Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases?

ScholarIQpmid

The PMID for Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases is on the source record.

What is the OpenAlex record for Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases?

ScholarIQopenalex

The OpenAlex for Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial